BIOCRYST PHARMACEUTICALS, INC. Royalty Expense
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Royalty Expense of $126.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RoyaltyExpense · last filed 2021-03-01
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for the quarter ending 2020-12-31 was $48.00K, a 80.33% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for the quarter ending 2020-09-30 was $9.00K, a 50.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for the quarter ending 2020-03-31 was $69.00K, a 20.69% decline year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for fiscal 2020 was $126.00K, a 66.40% decline from fiscal 2019.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for fiscal 2019 was $375.00K, a 20.38% decline from fiscal 2018.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for fiscal 2018 was $471.00K, a 15.89% decline from fiscal 2017.
- BIOCRYST PHARMACEUTICALS, INC. royalty expense for fiscal 2017 was $560.00K, a 39.30% increase from fiscal 2016.
| Period end | Royalty Expense 3 month | Royalty Expense 6 month | Royalty Expense 9 month | Royalty Expense 12 month |
|---|---|---|---|---|
| 2020-12-31 | $48.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $57.00K derived: sum of 2 quarters · filed 2021-03-01 | $57.00K derived: sum of 3 quarters · filed 2021-03-01 | $126.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $9.00K 10-Q · filed 2020-11-06 | $9.00K derived: sum of 2 quarters · filed 2020-11-06 | $78.00K 10-Q · filed 2020-11-06 | $322.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-07 | $69.00K 10-Q · filed 2020-08-07 | $313.00K derived: sum of 3 quarters · filed 2021-03-01 | $331.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $69.00K 10-Q · filed 2020-05-11 | $313.00K derived: sum of 2 quarters · filed 2021-03-01 | $331.00K derived: sum of 3 quarters · filed 2021-03-01 | $357.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $244.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $262.00K derived: sum of 2 quarters · filed 2021-03-01 | $288.00K derived: sum of 3 quarters · filed 2021-03-01 | $375.00K 10-K · filed 2021-03-01 |
| 2019-09-30 | $18.00K 10-Q · filed 2020-11-06 | $44.00K derived: sum of 2 quarters · filed 2020-11-06 | $131.00K 10-Q · filed 2020-11-06 | $201.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $26.00K 10-Q · filed 2020-08-07 | $113.00K 10-Q · filed 2020-08-07 | $183.00K derived: sum of 3 quarters · filed 2021-03-01 | $201.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $87.00K 10-Q · filed 2020-05-11 | $157.00K derived: sum of 2 quarters · filed 2021-03-01 | $175.00K derived: sum of 3 quarters · filed 2021-03-01 | $418.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $88.00K derived: sum of 2 quarters · filed 2021-03-01 | $331.00K derived: sum of 3 quarters · filed 2021-03-01 | $471.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $18.00K 10-Q · filed 2019-11-08 | $261.00K derived: sum of 2 quarters · filed 2019-11-08 | $401.00K 10-Q · filed 2019-11-08 | $530.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-06-30 | $243.00K 10-Q · filed 2019-08-08 | $383.00K 10-Q · filed 2019-08-08 | $512.00K derived: sum of 3 quarters · filed 2020-03-13 | $627.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-03-31 | $140.00K 10-Q · filed 2019-05-09 | $269.00K derived: sum of 2 quarters · filed 2020-03-13 | $384.00K derived: sum of 3 quarters · filed 2020-03-13 | $406.00K derived: sum of 4 quarters · filed 2020-03-13 |
| 2017-12-31 | $129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $244.00K derived: sum of 2 quarters · filed 2020-03-13 | $266.00K derived: sum of 3 quarters · filed 2020-03-13 | $560.00K 10-K · filed 2020-03-13 |
| 2017-09-30 | $115.00K 10-Q · filed 2018-11-08 | $137.00K derived: sum of 2 quarters · filed 2018-11-08 | $431.00K 10-Q · filed 2018-11-08 | $586.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-06-30 | $22.00K 10-Q · filed 2018-08-09 | $316.00K 10-Q · filed 2018-08-09 | $471.00K derived: sum of 3 quarters · filed 2019-03-14 | $614.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2017-03-31 | $294.00K 10-Q · filed 2018-05-09 | $449.00K derived: sum of 2 quarters · filed 2019-03-14 | $592.00K derived: sum of 3 quarters · filed 2019-03-14 | $619.00K derived: sum of 4 quarters · filed 2019-03-14 |
| 2016-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $298.00K derived: sum of 2 quarters · filed 2019-03-14 | $325.00K derived: sum of 3 quarters · filed 2019-03-14 | $402.00K 10-K · filed 2019-03-14 |
| 2016-09-30 | $143.00K 10-Q · filed 2017-11-08 | $170.00K derived: sum of 2 quarters · filed 2017-11-08 | $247.00K 10-Q · filed 2017-11-08 | $268.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-06-30 | $27.00K 10-Q · filed 2017-08-08 | $104.00K 10-Q · filed 2017-08-08 | $125.00K derived: sum of 3 quarters · filed 2018-03-12 | $130.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2016-03-31 | $77.00K 10-Q · filed 2017-05-08 | $98.00K derived: sum of 2 quarters · filed 2018-03-12 | $103.00K derived: sum of 3 quarters · filed 2018-03-12 | $545.00K derived: sum of 4 quarters · filed 2018-03-12 |
| 2015-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $26.00K derived: sum of 2 quarters · filed 2018-03-12 | $468.00K derived: sum of 3 quarters · filed 2018-03-12 | $528.00K 10-K · filed 2018-03-12 |
| 2015-09-30 | $5.00K 10-Q · filed 2016-11-08 | $447.00K derived: sum of 2 quarters · filed 2016-11-08 | $507.00K 10-Q · filed 2016-11-08 | $550.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-30 | $442.00K 10-Q · filed 2016-08-08 | $502.00K 10-Q · filed 2016-08-08 | $545.00K derived: sum of 3 quarters · filed 2017-02-27 | $545.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-31 | $60.00K 10-Q · filed 2016-05-09 | $103.00K derived: sum of 2 quarters · filed 2017-02-27 | $103.00K derived: sum of 3 quarters · filed 2017-02-27 | $108.00K derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-31 | $43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $43.00K derived: sum of 2 quarters · filed 2017-02-27 | $48.00K derived: sum of 3 quarters · filed 2017-02-27 | $121.00K 10-K · filed 2017-02-27 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $5.00K derived: sum of 2 quarters · filed 2015-11-06 | $78.00K 10-Q · filed 2015-11-06 | $95.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-06-30 | $5.00K 10-Q · filed 2015-08-07 | $78.00K 10-Q · filed 2015-08-07 | $95.00K derived: sum of 3 quarters · filed 2016-02-26 | $95.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | $73.00K 10-Q · filed 2015-05-08 | $90.00K derived: sum of 2 quarters · filed 2016-02-26 | $90.00K derived: sum of 3 quarters · filed 2016-02-26 | $94.00K derived: sum of 4 quarters · filed 2016-02-26 |
| 2013-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $17.00K derived: sum of 2 quarters · filed 2016-02-26 | $21.00K derived: sum of 3 quarters · filed 2016-02-26 | $98.00K 10-K · filed 2016-02-26 |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $4.00K derived: sum of 2 quarters · filed 2014-11-07 | $81.00K 10-Q · filed 2014-11-07 | $99.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $4.00K 10-Q · filed 2014-08-08 | $81.00K 10-Q · filed 2014-08-08 | $99.00K derived: sum of 3 quarters · filed 2015-03-02 | $213.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $77.00K 10-Q · filed 2014-05-09 | $95.00K derived: sum of 2 quarters · filed 2015-03-02 | $209.00K derived: sum of 3 quarters · filed 2015-03-02 | |
| 2012-12-31 | $18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $132.00K derived: sum of 2 quarters · filed 2015-03-02 | $132.00K 10-K · filed 2015-03-02 | |
| 2012-09-30 | $114.00K 10-Q · filed 2013-11-08 | $114.00K 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | $1.93M 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |